Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of BMS-986165 in moderate to severe Crohn's disease
jRCT2080224183Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Crohn's disease comparing BMS-986165 with Placebo (2 arms). Started Dec 2018; status: completed.
02
Drugs
deucravacitinib
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT2080224183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224183.